当前位置： SCI文献检索 > CANCER期刊下所有文献 > Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis.

Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis.

Abstract：

BACKGROUND:The specific activity of the non-receptor protein tyrosine kinase, Src, is increased in the majority of colon and rectal adenocarcinomas compared to normal mucosa. However, the prognostic significance of this difference is unknown. The objective of the current study was to determine if Src activity is a marker for poor clinical prognosis in colon carcinoma patients. As Src activation leads to expression of urokinase/plasminogen activator receptor (u-PAR), expression of Src and u-PAR were correlated with patient survival. METHODS:Tumors and adjacent normal colonic mucosae from 45 patients with colorectal carcinoma were screened for Src activity by the immune complex kinase assay. Expression of u-PAR was determined by enzyme linked immunoabsorbent assay. The primary tumor-to-normal mucosa ratios of activity were compared following classification and regression tree (CART) analysis to determine the prognostic significance of elevated specific Src activity. Expression of u-PAR was correlated with Src activity. RESULTS:By CART analysis, Src activity in tumors elevated more than twofold over normal mucosa was significant. Increased Src activity significantly correlated with Dukes stage, pT and pN classification, and increased u-PAR levels (P < 0.001). Kaplan Meier analysis showed a significant association between elevated Src activity and shorter overall survival of all patients (P = 0.0004) and of Dukes Stage A-C patients (P = 0.0037). In patients who underwent curative resection, a significant correlation with a decreased disease-free survival rate was found (P < 0.0001). Multivariate analysis revealed that elevated Src activity was a prognostic parameter independent of M classification (P = 0.0125, relative risk 3.54, 95% confidence interval 1.31 - 9.76). CONCLUSIONS:Src activity is an independent indicator of poor clinical prognosis in all stages of human colon carcinoma. These data suggest that Src-specific inhibitors may have a therapeutic role in inhibiting tumor progression and metastasis, and that measurement of Src activity may aid in selection of early stage patients for adjuvant therapy.

journal_name

Cancer

journal_title

Cancer

authors

Aligayer H,Boyd DD,Heiss MM,Abdalla EK,Curley SA,Gallick GE

doi

10.1002/cncr.10221

subject

Has Abstract

pub_date

2002-01-15 00:00:00

pages

344-51

issue

eissn

0008-543X

issn

1097-0142

journal_volume

pub_type

杂志文章

在线工具

Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis.